Comprehensive Solutions For Genome Analysis And Synthetic Biology Projects
Eurofins Genomics and Igenbio provide tailored services for sequencing and analysis of various organisms
(PresseBox) - icago IL, USA, 29.10.2014 - Eurofins Genomics, pioneer and key provider of next generation sequencing services (NGS), and Igenbio, leading provider of microbial bioinformatics and gene manipulation tools and services, have announced a co-operation agreement to combine their expertise in sequencing and analysis services for microbial, fungal and algal organisms.
With the cooperation, customers benefit from "one-stop-shopping" for complete genomics projects that deliver analysis results from the raw extracted DNA. Both companies together serve a worldwide market for their products and services.
"We take specific care to build up a technical and operational pipeline which is suitable to meet our quality standards and the high service level we want to provide to our customers", says Bruno Poddevin, Senior Vice President Eurofins Genomics. "The specific know-how and bioinformatics capabilities of Igenbio are an excellent fit to our portfolio for prokaryotic, yeast and fungal genome sequencing services."
"As global leader in next generation sequencing technologies, Eurofins has long been our preferred sequencing partner. With the increased integration we are now able to provide complete genome analysis, transcriptomics data integration along with gene manipulation tool set and for synthetic biology platform for our customers", says Vinayak Kapatral, President, and CEO of Igenbio, Inc.
Eurofins Genomics, a member of the Eurofins Group with facilities in Europe, the United States and Asia, is an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. The company's strength is its customer convenience and high quality services in industrial scale for the life science industries and academic research institutions around the world. For further information, please visit our website at eurofinsgenomics.com.
Igenbio, Inc is the leading commercial provider of microbial bioinformatics tools and services based on the ERGO? genome annotation platform, including ORF-calling, annotation, databases for genome comparison, metabolic analysis and metabolic reconstruction. The company's expertise in microbial genomics includes genome assembly annotations, comparative genomics and custom bioinformatics applications. ERGO? contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions representing over 8,700 networked metabolic and non-metabolic pathways. ERGO system has synthetic biology tools for gene manipulation with tools to integrate transcriptomics data. For further information, please visit our website at: http://www.igenbio.com
Eurofins Genomics, a member of the Eurofins Group with facilities in Europe, the United States and Asia, is an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. The company's strength is its customer convenience and high quality services in industrial scale for the life science industries and academic research institutions around the world. For further information, please visit our website at eurofinsgenomics.com.
Igenbio, Inc is the leading commercial provider of microbial bioinformatics tools and services based on the ERGO? genome annotation platform, including ORF-calling, annotation, databases for genome comparison, metabolic analysis and metabolic reconstruction. The company's expertise in microbial genomics includes genome assembly annotations, comparative genomics and custom bioinformatics applications. ERGO? contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions representing over 8,700 networked metabolic and non-metabolic pathways. ERGO system has synthetic biology tools for gene manipulation with tools to integrate transcriptomics data. For further information, please visit our website at: http://www.igenbio.com
" alt="Vida Green, Ltd. Adds to Advisory Council
Datum: 29.10.2014 - 09:30 Uhr
Sprache: Deutsch
News-ID 347760
Anzahl Zeichen: 2993
contact information:
Town:
Ebersberg
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 241 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Comprehensive Solutions For Genome Analysis And Synthetic Biology Projects"
steht unter der journalistisch-redaktionellen Verantwortung von
Eurofins Genomics GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
